Annals of Internal Medicine

• 

  Publication Venue For

  • The New Normal: Key Considerations for Effective Serious Illness Communication Over Video or Telephone During the Coronavirus Disease 2019 (COVID-19) Pandemic..  173:486-488. 2020
  • The Remote Misses of COVID-19. 2020
  • Biomedical Research in Times of Emergency: Lessons From History..  173:297-299. 2020
  • Dementia: A Personal Story..  172:433-434. 2020
  • Annals Graphic Medicine - Cicely Saunders: The Woman Who Changed How We Die.  171:W64-W64. 2019
  • Evidence Relating Health Care Provider Burnout and Quality of Care: A Systematic Review and Meta-analysis..  171:555-567. 2019
  • The 7 Habits of Highly Effective Cost-of-Care Conversations..  170:S33-S35. 2019
  • Expanding the Public Health Approach to Gun Violence Prevention..  169:723-724. 2018
  • Device Closure Versus Medical Therapy Alone for Patent Foramen Ovale in Patients With Cryptogenic Stroke: A Systematic Review and Meta-analysis..  168:335-342. 2018
  • Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2018..  168:210-220. 2018
  • Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review..  167:725-735. 2017
  • State Intimate Partner Violence-Related Firearm Laws and Intimate Partner Homicide Rates in the United States, 1991 to 2015..  167:536-543. 2017
  • The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial..  167:159-169. 2017
  • Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis..  167:103-111. 2017
  • Internet-delivered exercise and pain-coping skills training for chronic knee pain.  166:I13. 2017
  • At Last, a Good Estimate of the Magnitude of the Private-Sale Loophole for Firearms..  166:301-302. 2017
  • Battle of the Bulge: Aortic Aneurysm Management From Early Modernity to the Present..  166:291-296. 2017
  • Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs..  165:878-879. 2016
  • Emerging Infections and Blood Safety in the 21st Century..  165:57-58. 2016
  • Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial..  164:155-163. 2016
  • Using Behavioral Economics to Design Physician Incentives That Deliver High-Value Care..  164:114-119. 2016
  • Anatomical and functional testing did not differ for reducing CV events in suspected obstructive CAD.  163:JC11-JC11. 2015
  • Efficacy of Commercial Weight-Loss Programs.  162:501-501. 2015
  • In response.  163:805-806. 2015
  • Review: in adult outpatients, nurse-managed protocols improve hemoglobin A1c levels and blood pressure..  161:JC6. 2014
  • Summaries for patients. Trends in the use of stress testing to diagnose coronary heart disease..  161:I-28. 2014
  • Why information alone is not enough: behavioral economics and the future of genomic medicine..  161:605-606. 2014
  • Gender differences in time spent on parenting and domestic responsibilities by high-achieving young physician-researchers..  160:344-353. 2014
  • Commentary.  161:JC10. 2014
  • Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.  160:672-683. 2014
  • Review: In adult outpatients, nurse-managed protocols improve hemoglobin A_1c levels and blood pressure.  161:JC6-. 2014
  • Commentary.  158. 2013
  • Adding renal dysfunction to CHADS2 did not improve prediction of stroke or systemic embolism in AF.  158. 2013
  • Commentary.  158. 2013
  • Commentary.  158:JC6. 2013
  • Hepatitis C.  157:1-16. 2012
  • Red blood cell transfusion: In response.  157:754-755. 2012
  • Contraceptive transdermal patches or vaginal rings were associated with increased venous thrombosis.  157:JC4-JC4. 2012
  • The Mini-Cog had sensitivity similar to the longer 3MS for detecting cognitive impairment or dementia.  157. 2012
  • Apixaban reduced stroke and systemic embolism compared with warfarin in atrial fibrillation.  156. 2012
  • Commentary.  156. 2012
  • A hemorrhage of off-label use..  155:339. 2011
  • Reperfusion paradox in ST-segment elevation myocardial infarction..  155:389-391. 2011
  • Commentary.  155. 2011
  • Bolus and continuous/high- and low-dose diuretics had similar effects on symptoms and renal function in acute, decompensated HF.  155. 2011
  • Weekly INR self-testing did not reduce stroke, major bleeding, or death more than monthly clinic testing.  154. 2011
  • Re: Time of exposure and type of diabetes may determine treatment outcome of group clinics.  153:483. 2010
  • Review: Accuracy of monofilament testing for diagnosing peripheral neuropathy of the feet varies.  152. 2010
  • Sex differences in career development awardees' subsequent grant attainment.  152:617. 2010
  • Sex differences in attainment of independent funding by career development awardees..  151:804-811. 2009
  • Community-based interventions to promote blood pressure control in a developing country: A cluster randomized trial.  151:593-601. 2009
  • Prevalence of cognitive impairment without dementia in the United States (Annals of Internal Medicine (2008) 148, (427-434)).  151:291-292. 2009
  • Meta-analysis: retinal vessel caliber and risk for coronary heart disease..  151:404-413. 2009
  • Concomitant use of proton-pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI Commentary.  151. 2009
  • Correction: Prevalence of Cognitive Impairment Without Dementia.  151:291-291. 2009
  • Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure..  150:784-794. 2009
  • Erratum: Reliability of compendia methods for off-label oncology indications (Ann Intern Med. (2009) 150, (336-43))..  150:571. 2009
  • STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement..  150:206-215. 2009
  • Will running the numbers first violate the principles of patient-centered care?.  149:839. 2008
  • A personal-contact weight-loss maintenance intervention reduced weight regain in overweight and obese adults.  149:JC1-JC1. 2008
  • In patients with suspected CAD and normal ECG, a nomogram model based on clinical and exercise variables predicted mortality.  148:JC4-JC4. 2008
  • In response.  147:212. 2007
  • Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy..  145:426-434. 2006
  • Implications of the Multicenter Automatic Defibrillator Implantation Trial-II.  144:65-65. 2006
  • Erratum: Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis (Annals of Internal Medicine (2000) 132 (566-577)).  143:764-765. 2005
  • The costs of a national health information network..  143:165-173. 2005
  • Patient safety concerns arising from test results that return after hospital discharge..  143:121-128. 2005
  • Aggressive Treatment of High-Density Lipoprotein Cholesterol.  142:1025-1025. 2005
  • Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax..  142:601-610. 2005
  • A multimethod quality improvement intervention to improve preventive cardiovascular care: a cluster randomized trial..  141:523-532. 2004
  • Acute decompensation after removing a central line: practical approaches to increasing safety in the intensive care unit..  140:1025-1033. 2004
  • Providing free care to the uninsured: how much should physicians give?.  139:W78. 2003
  • Health CareAssociated Bloodstream Infections.  139:233-233. 2003
  • Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis..  139:244-252. 2003
  • Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules..  138:724-735. 2003
  • Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials..  138:445-452. 2003
  • Support for physician deception of insurance companies among a sample of Philadelphia residents..  138:472-475. 2003
  • Erratum: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease (Annals of Internal Medicine (2001) 135 (73-87)).  137:299. 2002
  • Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease..  137:298-299. 2002
  • Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial..  135:1019-1028. 2001
  • Physicians' willingness to participate in the process of lethal injection for capital punishment..  135:884-888. 2001
  • Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction..  135:870-883. 2001
  • Implications and challenges using practice guidelines for chronic angina..  135:527-529. 2001
  • Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data..  135:73-87. 2001
  • Truth in the most optimistic way..  134:1142-1143. 2001
  • Dizziness: state of the science..  134:823-832. 2001
  • Treatment of patients with myocardial infarction who present with a paced rhythm..  134:644-651. 2001
  • Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence..  134:600-620. 2001
  • The progression of fenfluramine-associated valvular heart disease assessed by echocardiography..  134:261-266. 2001
  • Serum homocysteine and stroke in atrial fibrillation..  134:253-254. 2001
  • Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple disease..  134:115-119. 2001
  • Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia..  133:864-876. 2000
  • Troglitazone-associated hepatotoxicity treated successfully with steroids..  133:751. 2000
  • Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review..  132:810-819. 2000
  • In search of a good death: observations of patients, families, and providers..  132:825-832. 2000
  • A systematic review of newer pharmacotherapies for depression in adults: evidence report summary..  132:743-756. 2000
  • The first positive: computing positive predictive value at the extremes..  132:804-809. 2000
  • Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis..  132:566-577. 2000
  • Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments..  132:191-200. 2000
  • Talking about treatment..  132:94. 2000
  • Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments..  131:721-728. 1999
  • ACI-TIPI clinical trial. Acute cardiac ischemia time-insensitive predictive instrument..  131:476-477. 1999
  • The medical student as patient..  131:225-226. 1999
  • Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial..  131:88-95. 1999
  • American College of Rheumatology Criteria for the Diagnosis of Vasculitis.  130:862-862. 1999
  • American College of Rheumatology Criteria for the diagnosis of vasculitis..  130:861. 1999
  • Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia..  130:810-820. 1999
  • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis..  130:789-799. 1999
  • Cost-effectiveness of diagnostic strategies for patients with chest pain..  130:709-718. 1999
  • The ethics of using Web technology to find research participants..  130:245-246. 1999
  • Doing everything..  130:165-166. 1999
  • Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment..  130:116-125. 1999
  • AIDS exceptionalism..  130:80. 1999
  • AIDS exceptionalism..  130:79-80. 1999
  • Computers and evaluation of clinical competence [10] (multiple letters).  130:244-245. 1999
  • Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication..  129:870-874. 1998
  • Transesophageal echocardiography: useful tool or expensive toy?.  129:748-749. 1998
  • Prophylaxis after sexual exposure to HIV..  129:671. 1998
  • Prophylaxis after sexual exposure to HIV..  129:671-672. 1998
  • Employment after coronary angioplasty or coronary bypass surgery in patients employed at the time of revascularization..  129:543-547. 1998
  • Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis..  129:345-352. 1998
  • Monitored isoniazid prophylaxis for low-risk tuberculin reactors..  128:1048. 1998
  • Doing everything..  128:869-870. 1998
  • Transesophageal echocardiography and atrial fibrillation: added value or expensive toy?.  128:685-687. 1998
  • Catheter-Related Bacteremia in Patients Undergoing Hemodialysis.  128:600-600. 1998
  • Catheter-related bacteremia in patients undergoing hemodialysis..  128:600. 1998
  • Monitoring warfarin therapy in patients with lupus anticoagulants..  128:504. 1998
  • Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis..  127:1051-1061. 1997
  • Risk stratification after myocardial infarction..  127:1040-1041. 1997
  • The Stroke Prevention Policy Model: linking evidence and clinical decisions..  127:704-711. 1997
  • Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument..  127:538-556. 1997
  • Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group..  127:356-364. 1997
  • Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis..  127:275-280. 1997
  • Monitoring warfarin therapy in patients with lupus anticoagulants..  127:177-185. 1997
  • Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS..  126:939-945. 1997
  • Hepatitis C and Cancer.  126:1003-1003. 1997
  • Thrombocytosis Associated with Low-Molecular-Weight Heparin.  126:742-742. 1997
  • Thrombocytosis associated with low-molecular-weight heparin..  126:742-743. 1997
  • Guidelines for risk stratification after myocardial infarction. American College of Physicians..  126:556-560. 1997
  • Risk stratification after myocardial infarction..  126:561-582. 1997
  • DNA and the immune system..  126:169-171. 1997
  • Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death..  126:1-12. 1997
  • Helping physicians recognize bedside rationing [9] (multiple letters).  126:921-922. 1997
  • Recognizing bedside rationing: clear cases and tough calls..  126:74-80. 1997
  • Quantitative assessment of procedural competence. A prospective study of training in endoscopic retrograde cholangiopancreatography..  125:983-989. 1996
  • Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators..  125:891-900. 1996
  • Hepatitis C..  125:658-668. 1996
  • Testing with Antineutrophil Cytoplasmic Antibody To Diagnose Wegener Granulomatosis.  125:622-622. 1996
  • Diuretics and sudden cardiac death..  125:347. 1996
  • Factors associated with do-not-resuscitate orders: patients' preferences, prognoses, and physicians' judgments. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment..  125:284-293. 1996
  • Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group..  125:270-279. 1996
  • Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party..  125:161-172. 1996
  • Thrombocytosis associated with low-molecular-weight heparin..  125:157. 1996
  • Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators..  125:35-39. 1996
  • Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group..  124:1031-1038. 1996
  • Fact or fiction?.  124:1016-1017. 1996
  • The breakthrough..  124:345-347. 1996
  • Health values of the seriously ill..  124:279. 1996
  • Hypernatremia in hospitalized patients..  124:197-203. 1996
  • BECK DEPRESSION INVENTORY (VOL 122, PG 913, 1995).  123:966-966. 1995
  • The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis..  123:925-932. 1995
  • Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study..  123:817-822. 1995
  • Noninvasive carotid artery testing..  123:633-634. 1995
  • Nonabandonment: medical ethics..  123:473. 1995
  • Nonabandonment: medical ethics..  123:474. 1995
  • Alopecia associated with fluconazole therapy..  123:354-357. 1995
  • Case-finding instruments for depression in primary care settings..  122:913-921. 1995
  • Health values of the seriously ill. SUPPORT investigators..  122:514-520. 1995
  • Noninvasive carotid artery testing. A meta-analytic review..  122:360-367. 1995
  • Stroke prevention guidelines..  122:235-236. 1995
  • The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments..  122:191-203. 1995
  • Erratum: Medical treatment of stroke prevention (Annals of Internal Medicine (1994) 121 (41-53)).  122:885. 1995
  • Changes in mortality after myocardial revascularization in the elderly. The national Medicare experience..  121:919-927. 1994
  • Fever: blessing or curse?.  121:982. 1994
  • The value of exercise thallium imaging..  121:891-893. 1994
  • More on the GUSTO Trial..  121:818. 1994
  • NIH conference. HIV vaccine development: a progress report..  121:603-611. 1994
  • Cryptosporidium spread in a group residential home..  121:467-468. 1994
  • Management of atrial fibrillation..  121:466-467. 1994
  • Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding..  121:278-230. 1994
  • Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group..  121:174-180. 1994
  • Don't share razors or toothbrushes..  121:153-154. 1994
  • The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study..  121:100-108. 1994
  • GUIDELINES FOR MEDICAL-TREATMENT FOR STROKE PREVENTION.  121:54-55. 1994
  • Medical treatment for stroke prevention..  121:41-53. 1994
  • Utility and limitations of claims data..  120:1049. 1994
  • The last word on GUSTO, for now..  120:970. 1994
  • Holding GUSTO up to the light. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries..  120:876-881. 1994
  • Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study..  120:111-117. 1994
  • Antiplatelet agents reduce risks for death, stroke, myocardial infarction, deep venous thrombosis, and arterial occlusion.  121:4-6. 1994
  • Comparison of clinical outcomes for women and men after acute myocardial infarction.  120:638-645. 1994
  • Scorecard cardiovascular medicine. Its impact and future directions..  120:65-70. 1994
  • Withdrawal of digoxin after treatment of chronic heart failure.  120:1. 1994
  • When and whom to screen..  119:1150-1151. 1993
  • Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research..  119:844-850. 1993
  • Body weight change, all-cause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial..  119:749-757. 1993
  • Diagnosing Sinusitis.  119:92-92. 1993
  • Diagnosing sinusitis..  119:92. 1993
  • Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia..  118:850-855. 1993
  • The effectiveness of ovarian cancer screening. A decision analysis model..  118:838-843. 1993
  • NIH conference. New insights into common variable immunodeficiency..  118:720-730. 1993
  • Publication criteria for statistical prediction models..  118:231-232. 1993
  • Value of the history and physical in identifying patients at increased risk for coronary artery disease..  118:81-90. 1993
  • Early ischemia after myocardial infarction in low-risk patients.  119:82. 1993
  • Morbidity and mortality after first myocardial infarction.  118:52. 1993
  • Failure of exercise to reduce blood pressure.  116:15. 1992
  • Predicting coronary disease from a treadmill exercise score.  116:23. 1992
  • Stunned myocardium in the toxic shock syndrome..  117:912-913. 1992
  • Survival after diagnosis of idiopathic dilated cardiomyopathy.  118:19. 1992
  • Pancytopenia from using trimethoprim and methotrexate..  117:877-878. 1992
  • Assessing housestaff diagnostic skills using a cardiology patient simulator..  117:751-756. 1992
  • Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination..  117:705-710. 1992
  • HIV transmission in a dental practice..  117:793-794. 1992
  • Posey palsy..  117:795. 1992
  • The influence of hyperglycemia on outcome of cerebral infarction..  117:449-456. 1992
  • Do restraints prevent falls?.  117:443. 1992
  • Do restraints prevent falls?.  117:442-443. 1992
  • Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction..  117:18-24. 1992
  • Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy..  116:896-900. 1992
  • Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment?.  116:791-797. 1992
  • Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias?.  116:785-790. 1992
  • The art of observation: William Osler and the method of Zadig..  116:863-866. 1992
  • Clinical trials: to terminate or not to terminate. The VA Cooperative Studies Group on AIDS..  116:699-700. 1992
  • Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver..  116:624-629. 1992
  • Wilson disease--penicillamine therapy and late presentation..  116:424. 1992
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma..  116:183-189. 1992
  • Cardiogenic shock after acute myocardial infarction.  116:58. 1992
  • Failure of exercise to reduce blood pressure.  116:15. 1992
  • Predicting coronary disease from a treadmill exercise score.  116:23. 1992
  • Transparent polyurethane-film catheter dressings: A meta-analysis.  117:58. 1992
  • A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).  115:946-951. 1991
  • LOWERING THE COST OF PRESCRIPTION DRUGS - REPLY.  115:749-749. 1991
  • Lowering the cost of prescription drugs..  115:748-749. 1991
  • Cost effectiveness of treating asymptomatic HIV infection..  115:655-656. 1991
  • Can physician education lower the cost of prescription drugs? A prospective, controlled trial..  115:116-121. 1991
  • Underestimating disability..  115:70. 1991
  • Distal and proximal colon adenomas..  114:603-604. 1991
  • Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy..  114:539-544. 1991
  • Resource center for occupational and environmental medicine..  114:607. 1991
  • Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients..  114:145-146. 1991
  • The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network..  114:119-127. 1991
  • AIDS vaccines: progress and unmet challenges..  114:161-162. 1991
  • Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction - Phase 5 randomized trial.  115:42-43. 1991
  • Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing.  114:30. 1991
  • Risk for colon adenomas in patients with rectosigmoid hyperplastic polyps..  113:760-763. 1990
  • Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography..  113:575-579. 1990
  • Treatment of mildly symptomatic human immunodeficiency virus (HIV) infection..  113:635-636. 1990
  • Bone marrow transplantation: what is the question?.  113:340-341. 1990
  • Left ventricular performance and clinical outcome after repeat balloon aortic valvuloplasty..  113:250-252. 1990
  • Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).  112:812-821. 1990
  • Driving-impaired patients leaving the emergency department. The problem of inadequate instructions..  112:365-370. 1990
  • Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris..  112:303-305. 1990
  • Abdominal obesity and breast cancer risk..  112:182-186. 1990
  • The time has come for vascular medicine..  112:138-139. 1990
  • Bone marrow transplantation for patients with myelodysplasia: Pretreatment variables and outcome.  112:590-597. 1990
  • Liver enzymes and liver biopsy (I: Reply).  112:311. 1990
  • Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management..  111:1010-1022. 1989
  • Mild cystic fibrosis linked to chromosome 7q22 markers with an uncommon haplotype..  111:797-801. 1989
  • Intravenous pyelography before hysterectomy..  111:541. 1989
  • Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?.  111:473-478. 1989
  • Reply to a letter on carotid endarterectomy..  111:540-541. 1989
  • Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course..  111:368-376. 1989
  • Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial..  110:685-690. 1989
  • Mild cystic fibrosis in a consanguineous family..  110:599-605. 1989
  • Standard formats for electronic transfer of clinical data..  110:333-335. 1989
  • Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial..  110:119-124. 1989
  • Effect of a geriatric consultation team on functional status of elderly hospitalized patients. A randomized, controlled clinical trial..  110:79-84. 1989
  • Diagnostic evaluation of the carotid arteries. Health and Public Policy Committee, American College of Physicians..  109:835-837. 1988
  • When and how to study the carotid arteries..  109:805-818. 1988
  • Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma..  109:114-117. 1988
  • Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis..  108:658-662. 1988
  • The risk for systemic embolization associated with percutaneous balloon valvuloplasty in adults. A prospective comprehensive evaluation..  108:557-560. 1988
  • Certification in diagnostic laboratory immunology..  108:458-459. 1988
  • The future internist. The Task Force on the Future Internist, American Board of Internal Medicine..  108:139-141. 1988
  • Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation..  107:809-816. 1987
  • Randomization in clinical trials..  107:790. 1987
  • Risk factors for airflow obstruction in recipients of bone marrow transplants..  107:648-656. 1987
  • Exercise treadmill score for predicting prognosis in coronary artery disease..  106:793-800. 1987
  • Isotope-dilution assay for urinary methylmalonic acid in the diagnosis of vitamin B12 deficiency. A prospective clinical evaluation..  106:707-710. 1987
  • Localizing coronary artery obstructions with the exercise treadmill test..  106:53-55. 1987
  • Idiopathic facial nerve paralysis and acute myocardial infarction..  105:304-305. 1986
  • Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients..  104:461-466. 1986
  • Certification in diagnostic laboratory immunology.  104:435. 1986
  • Methylxanthines as adenosine receptor antagonists..  103:643. 1985
  • An analysis of the knowledge base of practicing internists as measured by the 1980 recertification examination..  102:385-389. 1985
  • Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia..  100:777-782. 1984
  • The anxiety disorders..  100:558-564. 1984
  • Very low calorie diets: their efficacy, safety, and future..  99:675-684. 1983
  • Early discharge after acute myocardial infarction..  99:528-538. 1983
  • Neurologic manifestations of essential thrombocythemia..  99:513-518. 1983
  • Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis..  99:334-336. 1983
  • Cimetidine and gastric carcinoma..  98:673. 1983
  • Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings..  98:461-466. 1983
  • ASSESSING TREATMENTS WITH CYCLOPHOSPHAMIDE - COMMENT.  98:1027-1027. 1983
  • Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years..  98:76-85. 1983
  • Kaposi's sarcoma and hepatitis B vaccine..  97:786-787. 1982
  • Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy..  97:165-170. 1982
  • Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation..  97:182-189. 1982
  • Induction of cellular immunity to Coccidioides immitis after sensitization with dinitrochlorobenzene..  96:329-331. 1982
  • Osteomalacia after parathyroidectomy in patients with uremia..  96:34-39. 1982
  • Clinical features of types A and B food-borne botulism..  95:442-445. 1981
  • Computed tomography brain scanning in alcohol withdrawal seizures. Value of the neurologic examination..  94:519-522. 1981
  • Dermatitis herpetiformis: the skin and the gut..  93:857-874. 1980
  • Hypophosphatemic osteomalacia: association with prostatic carcinoma..  93:275-278. 1980
  • Idiopathic thrombocytopenic purpura: mother and neonate..  92:128-129. 1980
  • Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications..  91:450-458. 1979
  • Campylobacter enteritis: clinical and epidemiologic features..  91:179-185. 1979
  • Splenectomy in sickle-cell disease..  91:320. 1979
  • Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency..  90:917-920. 1979
  • Antecedent renal disease and the outcome of pregnancy..  90:747-751. 1979
  • Hairy cell leukemia-associated familial lymphoproliferative disorder: immunologic abnormalities in unaffected family members..  90:174-179. 1979
  • Valve resection for endocarditis..  90:277-278. 1979
  • Standards for practice: effectiveness and acceptance..  89:826-828. 1978
  • The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations..  89:660-676. 1978
  • Combination chemotherapy for primary amyloidosis reconsidered..  89:572-573. 1978
  • Lymph-node bacilliform bodies resembling those of Whipple's disease in a patient without intestinal involvement..  89:64-66. 1978
  • Carpal tunnel syndrome secondary to carpopedal spasm..  88:804-805. 1978
  • Hypothalamic insufficiency: the cause of hypopituitarism in sarcoidosis..  88:589-594. 1978
  • B-cell lymphosarcoma cell leukemia: dynamics of surface-membrance immunoglobulin. Value for differentiation from chronic lymphocytic leukemia..  88:317-322. 1978
  • Waldenström's macroglobulinemia and mononeuritis multiplex..  88:360-361. 1978
  • Acetaminophen and liver disease..  88:129. 1978
  • Amebiasis: epidemiologic studies in the United States, 1971-1974..  88:89-97. 1978
  • Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results..  87:656-663. 1977
  • cAMP and calcemia..  86:820-822. 1977
  • Letter: Pericarditis in a case of early daunorubicin cardiomyopathy..  85:339-341. 1976
  • Bacterial endocarditis caused by Oerskovia turbata..  83:664-666. 1975
  • Human-to-human transmission of Pseudomonas pseudomallei..  83:512-513. 1975
  • Letter: Pneumococcemia with sarcoid-infiltrated spleen..  82:847-848. 1975
  • Meningeal mycosis fungoides: clinical and cellular characteristics..  82:499-505. 1975
  • Resolution of primary amyloidosis during chemotherapy. Studies in a patient with nephrotic syndrome..  82:466-473. 1975
  • The American Board of Internal Medicine recertification examination: process and results..  82:577-581. 1975
  • Editorial: Thalassemia major: a problem of iron overload..  81:262-263. 1974
  • Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis..  78:509-513. 1973
  • Type II congenital dyserythropoietic anemia..  77:371-376. 1972
  • Origin of pleural fluid amylase in esophageal rupture..  76:985-986. 1972
  • Byssinosis and chronic bronchitis among cotton textile workers..  76:423-433. 1972
  • Cytogenetic studies and their clinical correlates in adults with acute leukemia..  75:353-360. 1971
  • Acute renal failure and pigmentation due to phenazopyridine (Pyridium)..  72:89-91. 1970
  • Isopotential surface maps..  70:1048. 1969
  • Clinical implications of isopotential surface maps..  69:919-928. 1968
  • Primary thrombosis of the axillary and subclavian veins..  35:454-463. 1951
  • Annals Graphic Medicine - I'd Want a Natural Death 2016
  • Annals Graphic Medicine - Please Don't Use Patient Names 2016
  • A hemorrhage of off-label use.  155:339-339. 2011